164 related articles for article (PubMed ID: 7645976)
1. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
[TBL] [Abstract][Full Text] [Related]
2. Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.
Korabiowska M; Brinck U; Mirecka J; Kellner S; Marx D; Schauer A
In Vivo; 1995; 9(5):433-8. PubMed ID: 8900920
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of cerbB3 in naevi and malignant melanomas.
Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
[TBL] [Abstract][Full Text] [Related]
4. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
5. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
6. [Skin melanomas of the head and neck: therapeutic value of cervical lymphatic dissection].
Bujía J; Wilmes E; Landthaler M
An Otorrinolaringol Ibero Am; 1992; 19(5):413-20. PubMed ID: 1443459
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of the morphological traits of skin melanoma of the head and neck].
Parshikova SM; Ragimov IR
Arkh Patol; 1985; 47(9):74-81. PubMed ID: 4074159
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.
Korabiowska M; Betke H; Kellner S; Stachura J; Schauer A
Anticancer Res; 1997; 17(5A):3697-700. PubMed ID: 9413226
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
11. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
[TBL] [Abstract][Full Text] [Related]
12. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.
Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z
Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497
[TBL] [Abstract][Full Text] [Related]
14. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
Döme B; Somlai B; Tímár J
Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
[TBL] [Abstract][Full Text] [Related]
15. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
19. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
20. Beta3 integrin expression in melanoma predicts subsequent metastasis.
Hieken TJ; Farolan M; Ronan SG; Shilkaitis A; Wild L; Das Gupta TK
J Surg Res; 1996 Jun; 63(1):169-73. PubMed ID: 8661192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
